Badrilla
Badrilla公司概况
Badrilla公司创立于2003年，是一家为从事分子心血管研究的科研工作者提供上等产品的生命科学公司，客户来自包括制药、生物技术企业以及科研单位等。Badrilla结合精细有机化学、蛋白化学等精湛的专长以及翻译后修饰蛋白的专业知识协助研究者开展心血管领域做***的研究，比如研究协调心脏兴奋收缩的相关蛋白，心律失常和病理性肥大，以及适应不佳反应导致心脏衰竭等课题。过去十几年里，Badrilla的产品成功的支持血管生化领域的重大发现，公司也获得了广泛赞誉，这份荣誉来自世界范围内知名科学家使用本公司产品而发表的数据。与客户携手并进，Badrilla将一如既往的**产品和服务，并扩展和加强在心血管领域领头羊的地位，努力和广大科研工作者实现互惠互利。
使命
Badrilla致力于开发高品质试剂，使科研工作者、研究赞助商能在心血管科学领域做出新的突破，为相关病患带来福音。
Badrilla主要提供心血管靶标单克隆及多克隆抗体(心血管蛋白及磷酸化蛋白靶标)、标签抗体、硝基酪氨酸抗体、SUMO化蛋白捕获与检测试剂盒、抑制剂等。
Company Profile
Badrilla Ltd, founded in 2003, is an established life science company providing high quality products for the molecular cardiovascular researcher located within major pharmaceutical, biotech, and academic establishments worldwide. Badrilla assists researchers in combining its expertise of meticulous organic and protein chemistry with its knowledge of the post-translational modification of the proteins that coordinate cardiac excitation-contraction coupling, cardiac arrhythmia and hypertrophy, and the maladaptive response leading to heart failure, in order to produce research tools of the highest integrity and broadest application.Over the past ten years Badrilla products have helped to underpin key discoveries in cardiac biochemistry and the Company has garnered a wealth of published data from respected scientists worldwide. Working in concert with its Clients, Badrilla continues to develop new products and services which will both expand and strengthen its focussed position to mutual benefit.